Publication | Closed Access
Salicylate enhances the response of prostate cancer to radiotherapy
13
Citations
38
References
2019
Year
Our results show that SAL can enhance RT responses in PrCa. Salsalate is a promising agent to investigate this concept in prospective clinical trials of PrCa in combination with RT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1